Exemple de utilizare a Interruption or discontinuation în Engleză și traducerile lor în Română
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Interruption or discontinuation of treatment.
In rare cases,the adverse reactions required interruption or discontinuation of the illumination.
Dose interruption or discontinuation may be required as described in Table 3.
Skin reactions are very common and treatment interruption or discontinuation may be required.
In rare cases, interruption or discontinuation of illumination may be necessary.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment should be considered.
TMZ dosing interruption or discontinuation duringconcomitant radiotherapy and TMZ.
Management of infections may require either temporary interruption or discontinuation of BLINCYTO(see section 4.2).
TMZ dosing interruption or discontinuation during concomitant radiotherapy and TMZ.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered.
In such patients, interruption or discontinuation of treatment must be considered(see section 4.8).
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered.
Lenalidomide interruption or discontinuation should be considered for grade 2 or 3 skin rash.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered.
Pomalidomide interruption or discontinuation should be considered for Grade 2-3 skin rash.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered.
Interruption or discontinuation of lenalidomide should be considered for other forms of skin reaction depending on severity.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered.
If medically indicated, earlier interruption or discontinuation of peginterferon alfa and ribavirin may be needed.
If a diagnosis of infection is made,institute appropriate treatment promptly and consider interruption or discontinuation of Afinitor.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment must be considered(see section 4.8).
Any abnormalities should be evaluated promptly and appropriate measures taken,which may also include dose reduction, interruption or discontinuation.
Severe symptoms such as eruptions followed by desquamation which lead to interruption or discontinuation of docetaxel treatment were reported(see section 4.2).
While taking Afinitor, be vigilant for symptoms and signs of infection; if a diagnosis of infection is made,institute appropriate treatment promptly and consider interruption or discontinuation of Afinitor.
In patients with mild hepatic impairment(Child Pugh A), treatment interruption or discontinuation for management of adverse reactions should be considered.
For paediatric patients, based on toxicities(see Table 6),up to three levels of dose modification can be made before dose interruption or discontinuation is considered.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment should be considered.
If there is evidence of new or worsening liver dysfunction(including clinically significant elevation of liver enzymes and/or symptoms such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly) in patients using PREZISTA used in combination with cobicistat or low dose ritonavir, interruption or discontinuation of treatment should be considered promptly.
If there is evidence of worsening liver disease in such patients, interruption or discontinuation of treatment should be considered.
If there is evidence of new or worsening liver dysfunction(including clinically significant elevation of liver enzymes and/or symptoms such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly)in patients using PREZISTA/ritonavir, interruption or discontinuation of treatment should be considered promptly.